Journal of Medicinal Chemistry p. 73 - 78 (1991)
Update date:2022-08-11
Topics:
Ricouart, A.
Gesquiere, J. C.
Tartar, A.
Sergheraet, C.
A new class of serine/threonine protein kinase inhibitors was designed by associating, in the same structure, mimics of both the ATP binding site and a protein substrate.Among the several potent antagonists which were obtained, the most active consists of isoquinoline-5-sulfonamide, as ATP mimic, and Ser-Arg6, as peptidic moiety, bound by a -NH(CH2)2NH(CH2)2CO- linker.This compound, with a Ki of 0.1 μM toward protein kinase C (PKC) and 0.004 μM toward cyclic AMP dependent protein kinase (PKA), is respectively 60- and 750-fold more active than the commercial inhibitor H-7.
View MoreContact:86-536-8866010
Address:NO.4455 EAST FUSHOU ST. WEIFANG DEVELOPMENT ZONE, SHANDONG, CHINA
BAODING SINO-CHEM INDUSTRY CO.,LTD
Contact:0312-5956088
Address:NO.8 FUXING ROAD,CHINA
Contact:+86-0592 5353131
Address:No.56 Guani Road Software Park 2,Siming District
XI'AN CHUKANG BIOTECHNOLOGY CO.,LTD
Contact:29-63685658 63685359
Address:Room 3-1202,Building 1,Oriental oasis,East of Xianning Road,Xi'an,Shaanxi 710043 P.R.China
Hebei Lead Bio-Chemicals Co., Ltd.
website:http://www.ldbiochem.com
Contact:+86-311-87826503
Address:481, Heping West Road, Shijiazhuang,China
Doi:10.1021/bc500392x
(2014)Doi:10.1007/BF00846006
()Doi:10.1016/S0040-4039(00)79808-X
(1973)Doi:10.1021/ja0476258
(2004)Doi:10.1016/S0022-1139(99)00211-0
(2000)Doi:10.1246/bcsj.54.945
(1981)